• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER DUCT OCCLUDER II ADDITIONAL SIZES; OCCLUDER, PATENT DUCTUS, ARTERIOSUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER DUCT OCCLUDER II ADDITIONAL SIZES; OCCLUDER, PATENT DUCTUS, ARTERIOSUS Back to Search Results
Model Number 9-PDA2AS-04-04-L
Device Problem Material Separation (1562)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/31/2019
Event Type  Injury  
Event Description
On (b)(6) 2019, a 4x4 amplatzer duct occluder ii was selected for implant.While positioning the device, the delivery cable detached 12cm from the distal end.The connecting cable was removed and the detached portion was removed successfully with forceps.The procedure was successfully completed with another amplatzer duct occluder ii.
 
Manufacturer Narrative
The report of a fractured delivery wire was confirmed.The delivery wire was fractured through a spot weld just proximal to the distal coil.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications at the time of commercialization.The fracture appeared to be a tensile failure with no evidence of a torsional component.As a result of this finding, abbott is performing further investigation.
 
Manufacturer Narrative
Correction:the report of a fractured delivery wire was confirmed.The delivery wire was fractured through a spot weld just proximal to the distal coil.Videos of the procedure were received and analyzed by an abbott director of medical affairs.The anatomy and curvature of the delivery wire at the moment of the fracture were consistent with an interrupted ivc with azygous continuation.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications at the time of commercialization.A historical incident review, beginning 1jan2015 of all devices which use this component, found no similar incidents or nonconformances had occurred.Sem imaging determined the fracture appeared to be a tensile failure with no evidence of a torsional component.The degree of curvature required to traverse the interrupted ivc resulted in additional stress and was a likely contributing factor to the fractured delivery wire.Though there was no conclusive evidence of an underlying manufacturing or design related issue, abbott is performing further investigation.
 
Manufacturer Narrative
Correction: d2.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER DUCT OCCLUDER II ADDITIONAL SIZES
Type of Device
OCCLUDER, PATENT DUCTUS, ARTERIOSUS
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
MDR Report Key9368942
MDR Text Key168182137
Report Number2135147-2019-00412
Device Sequence Number1
Product Code MAE
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup,Followup
Report Date 01/06/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/25/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/30/2023
Device Model Number9-PDA2AS-04-04-L
Device Catalogue Number9-PDA2AS-04-04-L
Device Lot Number6689440
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/05/2019
Was the Report Sent to FDA? No
Date Manufacturer Received11/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-